Printer Friendly

Better differential diagnosis of iron deficiency anemia from beta-thalassemia trait/Demir eksikligi anemisinin beta-talasemi tasiyiciligindan ayirici tanisinin daha iyi yapilmasi.

Introduction

The most commonly encountered disorders with mild microcytic anemia are iron deficiency anemia (IDA) and thalassemia trait (TT) [1,2]. The gene frequency of [beta]-thalassemia, however, is high and varies considerably from area to area, having its highest rate of more than 10% around the Caspian Sea and Persian Gulf. [alpha]-thalassemia is very rare in Iran, and there is no clear report of the prevalence for the country as a whole. Results of genotyping for the two most common [alpha]-thalassemia single gene deletions (-[[alpha].sup.3.7] and -[alpha].sup.4.2]) showed that the -[[alpha].sup.3.7] deletion was a common cause of microcytic and hypochromic anemia in Iran [3]. The prevalence of the disorder in other areas is between 4-8%. In Isfahan, a city built around the river Zayandeh-Rood in the central part of Iran, the frequency rises to about 8%. In the Fars Province, in southern Iran, the gene frequency is also high and reaches 8-10% [4]. To date, many discrimination indices have been reported using red blood cell (RBC) indices obtained by automated blood count. Many authors have calculated the sensitivity and specificity of these indices in the distinction between IDA and TT [2]. They proposed that the diagnosis could be established without having to resort to the more time-consuming methods such as transferrin saturation (TS), ferritin and hemoglobin [A.sub.2] (Hb[A.sub.2]) levels. However, none of these indices showed a sensitivity and specificity of 100% in prediction of IDA and TT. Some showed considerable sensitivity for IDA or TT, but not specificity [5]. Youden's index provides an appropriate measure of validity of a particular technique or question by taking into account both sensitivity and specificity [6,7]. In this study, we compared the validity of various indices in differentiating [beta]-TT from IDA by calculating their sensitivity, specificity and Youden's index. In some published articles, the validity of all of the defined discrimination indices were compared in the same patient groups, and it was shown that the RBC count is one of the two most accurate indices available [8-11].

Materials and Methods

Totally 323 subjects (173 children and 150 adults) with microcytic anemia were involved in this study. We divided the patients into two categories according to age as 1 to 10 years and 11 to 57 years. The division was done using a method based on difference in red cell indices such as mean corpuscular volume (MCV) published by Hermiston and Mentzer [12]. Venous blood was drawn with the usual precautions after the patient had been lying quietly for at least 20 minutes. The hematological analyses were carried out with a Coulter Counter (M530, Coulter Electronics Ltd., Luton, UK) particle counter. Hb concentration, RBC count, and total leukocyte count were recorded, and liquid chromatography technique was used for determination of Hb[A.sub.2] [13]. Serum iron (SI), serum iron binding capacity (SIBC), serum ferritin, and Hb[A.sub.2] values were determined in all. Diagnosis of IDA was based on a Hb level of <11.4 and <12.9 g/dl and MCV of <81 and <84.8 fl in those younger or older than 10 years, respectively, and a ferritin value of <10 ng/ml and TS of <12% in both age groups. According to these criteria, 114 children and 56 adults of the 323 patients were diagnosed as IDA. The patients with Hb value <8.7 g/dl were excluded in order to not confuse more severe IDA with [beta]-TT. In the remaining 59 patients younger than 10 years and 94 patients older than 10 years, the diagnosis of TT was based on presence of microcytosis and elevated levels of Hb[A.sub.2] (>3.5%). RBC count and red blood cell distribution width (RDW) [14,15] were obtained with Coulter Counter and the other discrimination indices were calculated by using RBC indices as defined below:

Mentzer Index (MI): MCV/RBC [16],

Shine and Lal Index (S&L): MC[V.sup.2] x mean corpuscular hemoglobin (MCH) x 0.01[17],

England and Fraser (E&F): MCV-RBC-(5 x Hb)-k [18], k is calculated to be 4.54 in our counter as described in the published report [19],

Srivastava Index (SI): MCH/RBC [20],

Green and King Index (G&K): MCV2 x RDW/100 x Hb [21],

RDW Index (RDWI): MCV x RDW/RBC [22],

Mean Cell Hb Density (MCHD) Index: MCH/MCV [23],

Mean Density of Hb/Liter of Blood (MDHL) Index: MCHD x RBC [23].

Differential value for each of above indices was applied as given in the original published reports [6-22].

We calculated two hematological parameters including MDHL and MCHD in healthy male and female subjects and patients separately using data from Shafa Hospital based on the method described by Telmissani et al. [23]. The diagnostic method was that patients with values equal to or below the mean of healthy subjects were most likely to have IDA, and patients with values higher than the mean of healthy subjects were most likely to have [beta]-TT. We computed mean and median of MCHD and MDHL for those 323 patients and compared the obtained values to the normal values, which are shown in Table 6. We attempted to compare 10 different discrimination indices with respect to five parameters include sensitivity, specificity, positive predictive value, negative predictive value, and Youden's index.

Sensitivity and specificity were calculated according to standard formulas, namely: Sensitivity = (TP) / (TP + FN) and specificity = (TN) / (TN + FP), where TP = true positives, FN = false negatives, TN = true negatives and FP = false positives. The predictive values (PV), whether positive (+) or negative (-), were similarly calculated, with +PV being (TP) / (TP + FP) and -PV being (TN) / (TN + FN). Finally, Youden's index was calculated as follows: (Sensitivity + specificity)-100.

Results

Of the 323 patients, 170 (114 children, 56 adults) were diagnosed to have IDA and 153 (59 children, 94 adults) were diagnosed to have [beta]-TT. The hematological data of the groups are shown in Table 1. The different indices for patients younger or older than 10 years were calculated individually. The differential value for each index in differentiation between [beta]-TT and IDA and the number and proportion of correctly identified patients (true positives) calculated using these indices are shown in Table 2 (those younger than 10 years) and Table 4 (those older than 10 years). The sensitivity, specificity, positive and negative predictive values and Youden's index of each index in differentiation between [beta]-TT and IDA are shown in Table 3 (those younger than 10 years) and Table 5 (those older than 10 years). All of the indices showed overlapping in the patients with [beta]-TT and IDA. The overlaps were between 12.5 and 21.1% in RDW and between 4.3 and 5.49 x 1012 in RBC for patients younger than 10 years, while these respective values were between 11.4 and 25.1% and between 4.38 and 5.94 x 1012 in those older than 10 years. None of the indices was completely sensitive or specific in differentiation between [beta]-TT and IDA. Youden's indices in decreasing order in patients younger than 10 years were as follows: S&L > RBC > SI > MI > E&F > MDHL > G&K > RDWI > RDW > MCHL, and in patients older than 10 years were: RDWI > RBC > MI > E&F > SI > MDHL > RDW > S&L > G&K > MCHL. The scatter-gram of the hematological data of all patients showed significant differences between these two disorders (Figure 1).

However, MDHL, which showed that patients with values equal to or below the mean of healthy subjects (for younger than 10 years: 1.71 in males and 1.98 in females; for older than 10 years: 1.80 in males and 1.76 in females) were most likely to have IDA and those whose MDHL value was greater than the mean were more likely to have [beta]-TT. We computed mean and median of MCHD and MDHL for these 323 patients and compared results with the normal values (Table 6). We found that mean and median MCHD values were very close to normal in both IDA and [beta]-TT patients, while mean and median MDHL values were significantly more than normal values in [beta]-TT and lower than normal in IDA patients (Table 7).

Discussion

The most frequently encountered diseases with mild microcytic anemia are TT and IDA. However, in addition to genetic counseling for identification of thalassemia carriers in order to prevent the birth of thalassemia patients, differentiating TT from IDA is warranted because the thalassemia heterozygote should not be given iron in a vain attempt to normalize MCV. The diagnosis of [beta]-TT is established by the presence of characteristic RBC microcytosis and elevated levels of Hb[A.sub.2] [24]. Decreased levels of SI, TS and ferritin with increased levels of SIBC are the main diagnostic criteria for IDA [25]. Less time-consuming methods are based on the calculation of discrimination indices from RBC indices obtained during routine complete blood count. However, later studies have shown that the different reported indices correctly identify only 61-91% of the patients with microcytic anemia due to TT or IDA. As each index showed overlapping values in patients with TT and IDA, none of them was entirely satisfactory in discriminating between these conditions [26]. We calculated each discrimination index in the same patient groups with [beta]-TT and IDA. In addition to calculating the sensitivity, specificity, positive predictive value and negative predictive value of each discrimination index, we also calculated Youden's index in their differentiation between [beta]-TT and IDA.

In 2007, Suad et al. [10] in their research work applied and compared nine well-documented discriminant functions in a population of 153 confirmed cases of microcytic anemias and measured validity using Youden's index. They showed that the E&F index had the highest Youden's index value (98.2%) in correctly differentiating between IDA and [alpha]--and [beta]-thalassemia minor, while the S&L index was found ineffective in differentiating between microcytic anemias in their study. Finally, they concluded that the E&F index showed with great sensitivity and specificity to be the best discriminant function to differentiate between IDA and thalassemia minor cases. Our data showed that the S&L index had the highest Youden's index, with a value of 89%, in correctly differentiating between IDA and [beta]-thalassemia minor among patients aged younger than 10 years, while RDW and RBC count indices showed the highest Youden's index, with values of 93% and 90%, respectively, in the patients older than 10 years.

[FIGURE 1 OMITTED]

In another research work, Ntaios et al. [11] examined the diagnostic accuracy of six discrimination indices in the differentiation between IDA and [beta]-TT. He calculated these indices in 373 patients (205 men, 168 women) with [beta]-TT and 120 patients (50 men, 70 women) with IDA, as well as their sensitivity, specificity, positive and negative prognostic value, efficiency, and Youden's index. The G&K index showed the highest reliability, followed by E&F, RBC count, MI, and RDWI. On the contrary, RDW completely failed to differentiate between IDA and [beta]-TT. G&K proved to be the most reliable index, as it had the highest sensitivity (75.06%), efficiency (80.12%), and Youden's index (70.86%) for the detection of [beta]-TT. In comparison, our data showed Youden's indices in decreasing order in patients younger than 10 years to be as follows: S&L > RBC > SI > MI > E&F > MDHL > G&K > RDWI > RDW > MCHL, and in patients older than 10 years as: RDWI > RBC > MI > E&F > SI > MDHL > RDW > S&L > G&K > MCHL. S&L, with the highest efficiency (92%), sensitivity (100%) and YI (89%) in the former group, and RDWI, with highest efficiency (93%), sensitivity (95%) and YI (86%) in latter group, proved to be the most reliable indices.

In recent research work published by Beyan et al. [9] in 2007, they attempted to evaluate the predictive value of these indices in the differential diagnosis of IDA and [beta]-TT in adult cases. The study consisted of 45 IDA cases (36 women and 9 men, age range 17-57 years) and 66 [beta]-TT cases (41 women and 25 men, age range 14-74 years). Patient groups were evaluated according to RBC, RDW, MI, S&L, E&F, SI, G&K, RDWI, and Ricerca index. Sensitivity, specificity, positive and negative predictive values, and Youden's index were calculated. They concluded that none of these formulations was superior to RBC value obtained from automated analyzers in adult cases with IDA and [beta]-TT, and that total body iron status and Hb[A.sub.2] level should be obtained for accurate differential diagnosis of IDA and [beta]-TT until more efficient tools are developed. Our data showed that some of those indices could be used as efficient tools for differentiating between these two disorders.

Youden's index takes into account both sensitivity and specificity and gives an appropriate measure of validity of a particular question or technique. In our study, Youden's index of RBC count and RDWI were the highest and they were the most reliable discrimination indices in differentiating [beta]-TT from IDA in patients older than 10 years. For patients younger than 10 years, the most reliable discrimination indices were RBC and S&L. These indices are not very important today given the availability of Hb electrophoresis. As physicians, how many of us memorize these formulas and use them in our daily practice in crowded outpatient settings? However, we do consider MCV and RBC and MI, which is easy to calculate. How many of us would be brave enough to not study Hb electrophoresis in a woman with mild hypochromic anemia unresponsive to iron therapy who was planning a pregnancy? Our calculated normal values of MCHD and MDHL were very close to those published by Telmissani et al. [23]. Although we found that mean and median values of MDHL in IDA were significantly lower than those in [beta]-TT and normal values, Youden's index of MDHL was not found to be adequately high in either age group.

In conclusion, in patients with microcytic anemia, if [beta]-TT or IDA is shown in a patient younger than 10 years with correct measures on S&L and RBC and in a patient older than 10 years with correct measures on RBC and RDW indices, the diagnoses are likely to be correct. However, in a small number of patients, it would still be necessary to study body iron status or Hb[A.sub.2] for accurate diagnosis.

Acknowledgement

This work was supported by the Research Centers of Thalassemia and Hemoglobinopathies and Physiology and the directors of these centers, Professors Mohammad Pedram and Alireza Sarkaki.

Received: November 10, 2007 Accepted: June 10, 2009

Gelis tarihi: 10 Kasim 2007 Kabul tarihi: 10 Haziran 2009

References

[1.] Wharton BA. Iron deficiency in children: detection and prevention. Br J Haematol 1999;106:270-80.

[2.] Lukens JN. The thalassemias and related disorders: an overview. In: Lee GR, et al., editors. Wintrobe's Clinical Hematology. 10th ed. Giza: Mass Publishing, 1999: 405-33.

[3.] Haghshenas M, Zamani J. [Thalassemia]. 1st ed. Shiraz; Shiraz University of Medical Sciences Publishing Center, 1997. [Book in Persian]

[4.] Neishabury M, Oberkanins C, Moheb LA, Pourfathollah AA, Kahrizi K, Keyhany E, Krugluger W, Najmabadi H. High prevalence of the -a3.7 deletion among thalassemia patients in Iran. Hemoglobin 2003;27:53-5.

[5.] Lin CK, Lin JS, Chen SY, Jiang ML, Chia CF. Comparison of hemoglobin and red blood cell distribution width in the differential diagnosis of microcytic anemia. Arch Pathol Lab Med 1992;116:1030-2.

[6.] Pekkanen J, Pearce N. Defining asthma in epidemiological studies. Eur Respir J 1999;14:951-7.

[7.] Burney PG, Chinn S, Britton JR, Tattersfield AE, Papacosta AO. What symptoms predict the bronchial response to histamine? Evaluation in a community survey of the bronchial symptoms questionnaire (1984) of the International Union Against Tuberculosis and Lung Disease. Int J Epidemiol 1989;18:165-73.

[8.] Demir A, Yarali N, Fisgin T, Duru F, Kara A. Most reliable indices in differentiation between thalassemia trait and iron deficiency anemia. Pediatr Int 2002;44:612-6.

[9.] Beyan C, Kaptan K, Ifran A. Predictive value of discrimination indices in differential diagnosis of iron deficiency anemia and beta-thalassemia trait. Eur J Haematol 2007;78:524-6.

[10.] Suad MA, Anwar M Al-A, Doa'a A. Validity assessment of nine discriminant functions used for the differentiation between iron deficiency anemia and thalassemia minor. J Trop Pediatr 2007;53:93-7.

[11.] Ntaios G, Chatzinikolaou A, Saouli Z, Girtovitis F, Tsapanidou M, Kaiafa G, Kontoninas Z, Nikolaidou A, Savopoulos C, Pidonia I, Alexiou-Daniel S. Discrimination indices as screening tests for beta-thalassemic trait. Ann Hematol 2007;86:487-91.

[12.] Hermiston ML, Mentzer WC. A practical approach to the evaluation of the anemia child. Pediatr Clin North Am 2002;49:877-91.

[13.] Turpelnen U. Liquid-chromatographic determination of hemoglobinA2. Clin Chem 1986;3216:999-1002.

[14.] Klee GG, Fairbanks VF, Pierre RV, Virgh D, O'Sullivan MB. Routine erythrocyte measurements in diagnosis of iron-deficiency anemia and thalassemia minor. Am J Clin Pathol 1976;66:870-7.

[15.] Bessman JD, Feinstein DI. Quantitative anisocytosis as a discriminant between iron deficiencies and thalassemia minor. Blood 1979;53:288-93.

[16.] Mentzer WC. Differentiation of iron deficiency from thalassemia trait. Lancet 1973;1:882.

[17.] Shine I, Lal S. A strategy to detect beta-thalassemia minor. Lancet 1977;1:692-4.

[18.] England JM, Fraser PM. Differentiation of iron deficiency from thalassemia trait by routine blood-count. Lancet 1973;1:449-52.

[19.] England JM, Fraser P. Discrimination between iron-deficiency and heterozygous-thalassemia syndromes in differential diagnosis of microcytosis. Lancet 1979;1:145-8.

[20.] Srivastava PC, Bevington JM. Iron deficiency and-or thalassemia trait. Lancet 1973;1:832.

[21.] Green R, King R. A new red blood cell discriminant incorporating volume dispersion for differentiating iron deficiency anemia from thalassemia minor. Blood Cells 1989;15:481-95.

[22.] Jayabose S, Giavanelli J, Levendoglu-Tugal O, Sandoval C, Ozkaynak F, Visintainer P. Differentiating iron deficiency anemia from thalassemia minor by using an RDW-based index. J Pediatr Hematol 1999;21:314.

[23]. Telmissani OA, Khalil S, George TR. Mean density of hemoglobin per liter of blood: a new hematologic parameter with an inherent discriminant function. Lab Haematol 1999;5:149-52.

[24.] Olivieri NF. The beta--thalassemias. N Engl J Med. 1999;341:99-109.

[25.] Oski FA. Iron deficiency in infancy and childhood. N Engl J Med 1993;329: 190-3.

[26.] Raper AB. Differentiation of iron-deficiency anaemia from thalassaemia trait. Lancet 1973;1:778.

Address for Correspondence: Dr. Fakher Rahim, Golsetan 1366, Ahwaz Jondishapour University of Medical Sciences, Ahwaz,Iran Phone: 00986113362411 E-mail: fakherraheem@yahoo.com

Fakher Rahim (1), Bijan Keikhaei (2)

(1) Research Center of Thalassemia & Hemoglobinopathies, Ahwaz Jondishapour University of Medical Sciences and Apadana Clinical Research Center, Apadana Private Hospital, Ahwaz, Iran

(2) Physiology Research Center, Ahwaz Jondishapour University of Medical Sciences, Ahwaz, Iran
Table 1. Hematological data of study groups

 IDA
 n = 170

 Younger than 10 years
 (n=114)

Hematological Range Mean [[+ or -] SD]
data

Hb (g/dl) 8.7-11.4 10.12 (0.72)
RBC 3.7-5.49 4.45 (0.56)
MCV (n) 51-80.7 69.70 (0.36)
MCH (pg) 14.7-26.7 22.12 (3.31)
MCHC (g/dL) 22-35.1 31.14 (3.46)
RDW (%) 12.5-24.2 14.20 (4.21)
SI ([micro]g/dl) 3.8-31 20.03 (8.01)
SIBC 275-480 378.60 (70.01)
([micro]g/dl)
Ferritin (ng/ml) 0.9-9.2 4.23 (2.01)
TS (%) 0.68-8.1 3.81 (2.10)

 IDA
 n = 170

 Older than 10 years
 (n=56)

Hematological Range Mean [[+ or -] SD]
data

Hb (g/dl) 8.7-12.9 10.25 (1.30)
RBC 3.57-5.94 4.48 (0.97)
MCV (n) 57.1-84.8 71.64 (8.56)
MCH (pg) 16-27.6 22.16 (3.47)
MCHC (g/dL) 24-40.4 30.23 (9.19)
RDW (%) 11.4-30.2 15.60 (6.11)
SI ([micro]g/dl) 4.8-37 21.09 (8.42)
SIBC 315-570 429.70 (72.1)
([micro]g/dl)
Ferritin (ng/ml) 1.2-9.9 4.57 (1.99)
TS (%) 0.85-10.05 4.42 (2.28)

 [beta]--TT
 n=153

 Younger than 10 years
 (n=59)

Hematological Range Mean [[+ or -] SD]
data

Hb (g/dl) 9.1-12.25 10.45 (0.92)
RBC 4.3-6.95 5.66 (0.58)
MCV (n) 50-75 58.25 (5.26)
MCH (pg) 16.4-24 18.59 (1.82)
MCHC (g/dL) 27-39.4 32.60 (2.9)
RDW (%) 10.5-21.1 11.79 (6.75)
SI ([micro]g/dl) 45-196 75.80 (29.1)
SIBC 224-425 321.70 (36.8)
([micro]g/dl)
Ferritin (ng/ml) 12-85.4 31.09 (6.79)
TS (%) 12.8-57 21.09 (1.15)

 [beta]--TT

 Older than 10 years
 (n=94)

Hematological Range Mean [[+ or -] SD]
data

Hb (g/dl) 8.7-15.4 11.6 (1.42)
RBC 4.38-7.71 5.94 (0.7)
MCV (n) 54-80 61.41 (5.21)
MCH (pg) 15-26 19.45 (2.00)
MCHC (g/dL) 24.1-47.3 36.12 (4.37)
RDW (%) 10.1-25.1 15.12 (2.37)
SI ([micro]g/dl) 58-262 88.01 (33.6)
SIBC 257-478 345.50 (47.34)
([micro]g/dl)
Ferritin (ng/ml) 12-92 37.05 (7.34)
TS (%) 15-67 26.84 (1.23)

[beta]-TT: Beta thalassemia trait; Hb: Hemoglobin; IDA: Iron deficiency
anemia; MCH: Mean corpuscular hemoglobin; MCHC: Mean corpuscular
hemoglobin concentration; MCV: Mean corpuscular volume; RBC: Red blood
cells; RDW: Red blood cell distribution width; SI: Serum iron; SIBC:
Serum iron binding capacity; TS: transferrin saturation

Table 2. The differential values of each discrimination index and
correctly identified number of patients in the group younger than 10
years

Differential values IDA [beta]--TT
 (n=114) (n=59)

E & F
 IDA > 0 105 ([dagger]) 17
 [beta]TT < 0 9 ([dagger]) 42
SI
 IDA > 3.8 ([dagger]) 105 ([dagger]) 11
 [beta]TT < 3.8 9 48
RBC
 IDA < 5 ([dagger]) 101 4
 [beta]TT > 5 13 ([dagger]) 55
MI
 IDA > 13 ([dagger]) 97 4
 [beta]TT < 13 17 ([dagger]) 55
RDW
 IDA > 14 99 29
 G & K< 14 15 30
 IDA > 65 ([dagger]) 97 10
 [beta]TT < 65 17 ([dagger]) 49
RDWI
 IDA > 220 ([dagger]) 82 2
 [beta]TT < 220 32 ([dagger]) 57
S&L
 IDA > 1530 ([dagger]) 101 0
 [beta]TT < 1530 13 ([dagger]) 59

Differential values Total correctly Percentage of correctly
 identified identified patients (%)
 patients (n=173)
E & F
 IDA > 0 147 (105+42) 85%
 [beta]TT < 0
 SI
 IDA > 3.8 153 (105+48) 89%
 [beta]TT < 3.8
RBC
 IDA < 5 151 (101+50) 90%
 [beta]TT > 5
MI
 IDA > 13 152 (97+55) 88%
 [beta]TT < 13
RDW
 IDA > 14 129 (99+30) 74%
 G & K< 14
 IDA > 65 146 (97+49) 84%
 [beta]TT < 65
RDWI
 IDA > 220 139 (82+57) 81%
 [beta]TT < 220
S&L
 IDA > 1530 160 (101+59) 92%
[beta]TT < 1530

([dagger]) True positives; [beta]TT: Beta thalassemia trait; IDA: Iron
deficiency anemia; E & F: England and Fraser index; G & K: Green and
King index; MI: Mentzer index; RBC: Red blood cells; RDW: Red blood
cell distribution width; RDWI: Red blood cell distribution width index;
SI: Srivastave index; S & L: Shine and Lal index

Table 3. Sensitivity, specificity, positive predictive value (PPV),
negative predictive value (NPV) and Youden's index of each
discrimination index in prediction of IDA and 3TT groups younger than
10 years

Group Sensitivity (%) Specificity (%) PPV (%) NPV (%)

S&L
 IDA 89 100 100 82
 [beta]TT 100 89 82 100
RBC
 IDA 89 93 96 81
 [beta]TT 93 89 81 96
MI
 IDA 85 93 96 76
 [beta]TT 93 85 76 96
SI
 IDA 92 81 91 84
 [beta]TT 81 92 84 91
RDWI
 IDA 72 97 98 64
 [beta]TT 97 72 64 98
G&K
 IDA 85 83 90 74
 [beta]TT 83 85 74 90
E&F
 IDA 92 71 86 82
 [beta]TT 71 92 82 86
MDHL
 IDA 80 72 85 66
 [beta]TT 72 80 66 85
RDW
 IDA 87 51 77 67
 [beta]TT 51 87 67 77
MCHD
 IDA 96 6 66 44
 [beta]TT 6 96 44 66

Group Youden's Index

S&L
 IDA 89
 [beta]TT
RBC
 IDA 82
 [beta]TT
MI
 IDA 79
 [beta]TT
SI
 IDA 73
 [beta]TT
RDWI
 IDA 69
 [beta]TT
G&K
 IDA 68
 [beta]TT
E&F
 IDA 63
 [beta]TT
MDHL
 IDA 54
 [beta]TT
RDW
 IDA 38
 [beta]TT
MCHD
 IDA 2
 [beta]TT

[beta]TT: Beta thalassemia trait; E & F: England and Fraser index;
G & K: Green and King index; IDA: Iron deficiency anemia; MI: Mentzer
index; RBC: Red blood cells; RDW, Red blood cell distribution width;
RDWI: Red blood cell distribution width index; SI, Srivastave index;
S & L: Shine and Lal index

Table 4. The differential values of each discrimination index and
correctly identified number of patients in the group older than 11
years

Differential values IDA [beta]--TT Total correctly
 (n=56) (n=94) identified patients
 (n=150)
RDWI
 IDA > 220 51 ([psi]) 5 140 (51+89)
 [beta]TT < 220 5 89 ([psi])
RBC
 IDA < 5 47([psi]) 6 135 (47+88)
 [beta]TT > 5 9 88 ([psi])
MI
 IDA > 13 45 ([psi]) 5 134 (45+89)
 [beta]TT < 13 11 89 ([psi])
E&F
 IDA > 0 52 ([psi]) 16 130 (52+78)
 [beta]TT < 0 4 78 ([psi])
SI
 IDA > 3.8 47 ([psi]) 15 126 (47+79)
 [beta]TT < 3.8 9 79 ([psi])
RDW
 IDA > 14 50 26 118 (50+68)
 S&LT<14 6 68
IDA > 1530 13 ([psi]) 1 106 (13+93)
 [beta]TT < 1530 43 93 ([psi])
G&K
 IDA > 65 52 ([psi]) 45 101 (52+49)
 [beta]TT < 65 4 49 ([psi])

Differential values Percentage of correctly
 identified patients (%)

RDWI
 IDA > 220 93%
 [beta]TT < 220
RBC
 IDA < 5 90%
 [beta]TT > 5
MI
 IDA > 13 89%
 [beta]TT < 13
E&F
 IDA > 0 87%
 [beta]TT < 0
SI
 IDA > 3.8 84%
 [beta]TT < 3.8
RDW
 IDA > 14 79%
 S&LT<14 6
IDA > 1530 70%
 [beta]TT < 1530
G&K
 IDA > 65 67%
 [beta]TT < 65

[psi] True positives; [beta]TT: Beta thalassemia trait; IDA: Iron
deficiency anemia; E & F: England and Fraser index; G & K: Green and
King index; MI: Mentzer index; RBC: Red blood cells; RDW: Red blood
cell distribution width; RDWI: Red blood cell distribution width
index; SI: Srivastave index; S & L: Shine and Lal index

Table 5. Sensitivity, specificity, positive predictive value (PPV),
negative predictive value (NPV) and Youden's index of each
discrimination index in prediction of IDA and [beta]TT groups in
patients older than 11 years

Group Sensitivity (%) Specificity (%) PPV (%) NPV (%)

RDWI
 IDA 91 95 91 95
 [beta]TT 95 91 95 91
RBC
 IDA 84 94 87 91
 [beta]TT 94 84 91 87
E&F
 IDA 93 83 76 95
 [beta]TT 83 93 95 76
MI
 IDA 80 95 90 89
 [beta]TT 95 80 89 90
SI
 IDA 93 83 76 95
 [beta]TT 83 93 95 76
MDHL
 IDA 79 87 79 87
 [beta]TT 87 79 87 79
RDW
 IDA 89 72 66 92
 [beta]TT 72 89 92 66
G&K
 IDA 93 52 54 92
 [beta]TT 52 93 92 54
S&L
 IDA 23 99 93 68
 [beta]TT 99 23 68 93
MCHD
 IDA 96 6 38 75
 [beta]TT 6 96 75 38

Group Youden's Index

RDWI
 IDA 86
 [beta]TT
RBC
 IDA 78
 [beta]TT
E&F
 IDA 76
 [beta]TT
MI
 IDA 75
 [beta]TT
SI
 IDA 68
 [beta]TT
MDHL
 IDA 66
 [beta]TT
RDW
 IDA 62
 [beta]TT
G&K
 IDA 45
 [beta]TT
S&L
 IDA 22
 [beta]TT
MCHD
 IDA 2
 [beta]TT

[beta]TT: Beta thalassemia trait; E & F: England and Fraser index; G &
K: Green and King index; IDA: Iron deficiency anemia; MI: Mentzer
index; RBC: Red blood cells; RDW, Red blood cell distribution width;
RDWI: Red blood cell distribution width index; SI: Srivastave index;
S & L: Shine and Lal index

Table 6. The normal values of Mean Cell Hemoglobin Density (MCHD) and
Mean Density of Hemoglobin per Liter of blood (MDHL)

Variables Male
 Group 1 Group 2

MCHD
 Median 0.32 0.32
Mean [[+ or -] SD] 0.32 (0.01) 0.319 (0.02)
MDHL
 Median 1.71 1.98
Mean [[+ or -] SD] 1.76 (0.22) 1.99 (0.28)

Variables Female
 Group 1 Group 2

MCHD
 Median 0.32 0.31
Mean [[+ or -] SD] 0.32 (0.01) 0.31 (0.01)
MDHL
 Median 1.8 1.76
Mean [[+ or -] SD] 1.8 (0.19) 1.78 (0.17)

Group 1: Normal subjects who were younger than 10 years; Group 2:
Normal subjects who were older than 10 years

Table 7. Mean Cell Hemoglobin Density (MCHD) and Mean Density of
Hemoglobin per Liter of blood (MDHL) according to age groups and sex in
IDA and [beta]TT

 Patients younger than 10 years

 Males
Differential
values IDA [beta]TT Total Percentage
 correctly of correctly
 identified identified
 patients patients (%)
MCHD
 IDA 38 27
 [beta]TT 1 2 40 (38+2) 58%
 Total 39 29

MDHL
 IDA 39 13
 [beta]TT 0 16 55 (39+16) 80%
 Total 39 29

 Patients younger than 10 years

 Females
Differential
values IDA [beta]TT Total Percentage
 correctly of correctly
 identified identified
 patients patients (%)
MCHD
 IDA 72 28
 [beta]TT 4 2 74 (72+2) 69%
 Total 76 30

MDHL
 IDA 4 3
 [beta]TT 22 27 81 (54+27) 77%
 Total 76 30

 Patients older than 10 year

 Males
Differential
values IDA [beta]TT Total Percentage
 correctly of correctly
 identified identified
 patients patients (%)
MCHD
 IDA 4 41
 [beta]TT 0 5 9 (5+4) 18%
 Total 4 46

MDHL
 IDA 3 9
 [beta]TT 1 37 40 (3+37) 80%
 Total 4 46

 Patients older than 10 year

 Females
Differential
values IDA [beta]TT Total Percentage
 correctly of correctly
 identified identified
 patients patients (%)
MCHD
 IDA 50 47
 [beta]TT 2 1 51 (50+1) 51
 Total 52 48

MDHL
 IDA 41 3
 [beta]TT 11 45 86 (41 +46) 86%
 Total 52 48
COPYRIGHT 2009 Aves Yayincilik
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Article
Author:Rahim, Fakher; Keikhaei, Bijan
Publication:Turkish Journal of Hematology
Article Type:Report
Geographic Code:7TURK
Date:Sep 1, 2009
Words:5037
Previous Article:Beta globin gene cluster haplotypes of the beta thalassemia mutations observed in the Denizli province of Turkey/Denizli yoresinde gozlenen beta...
Next Article:Primary autoimmune myelofibrosis: a report of three cases and review of the literature/ Primer otoimmun miyelofibrozis-uc olgunun sunumu ve...
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters